Waverton Investment Management Ltd Sells 11,789 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Waverton Investment Management Ltd cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 438,977 shares of the healthcare conglomerate’s stock after selling 11,789 shares during the quarter. UnitedHealth Group accounts for 3.5% of Waverton Investment Management Ltd’s portfolio, making the stock its 11th biggest holding. Waverton Investment Management Ltd’s holdings in UnitedHealth Group were worth $222,318,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $37,000. Highline Wealth Partners LLC bought a new position in UnitedHealth Group during the third quarter worth about $55,000. Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $57,000. Finally, DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Down 7.3 %

NYSE:UNH opened at $465.58 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $428.46 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. The business’s 50-day moving average price is $519.27 and its two-hundred day moving average price is $560.44. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.